Beyond Dementia Coalition helps caregivers navigate the unique challenges of dementia and prepare communities for a growing public health crisis.

The first Alzheimer's blood test cleared by the Food And Drug Administration is poised to change the way doctors diagnose and treat the disease.

A survey of 1,700 Americans 45 and older found that 79% would want to know if they were in the early stages of Alzheimer's disease.

Hackman was also in the advanced stages of Alzheimer's disease and likely had not eaten for a long time, according to the new report. The actor, 95, had been in poor health for some time.

House Bill 238 would expand training for officers on identifying and responding to situations where someone with Alzheimer's or other degenerative diseases needs help.

Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband isn't sure if it made a difference.

About 40% of dementia cases could be prevented or delayed by healthy lifestyle choices and preventive medicine. Here's a tool to gauge your brain care and track your progress.

A study of cells from 84 brains finds that Alzheimer's has two distinct phases, and that one type of neuron is especially vulnerable.

Older Black Americans are about twice as likely to develop Alzheimer’s or other dementias as older white Americans, according to the Alzheimer’s Association. Yet, awareness and resources to address these diseases within the Black community have often lagged behind. That’s where Alter Dementia steps in.

A new generation of blood tests can help diagnose Alzheimer’s disease. But many doctors don’t yet know how to use them.

The government is launching an experimental program to ease the burden on caregivers of people with Alzheimer's. The idea is to keep patients healthier without exhausting their families.

The approval of Eli Lilly's Kisunla provides a new option for patients in the early stages of the incurable, memory-destroying ailment.

The brain appears to rely on synchronized waves to wash out waste products, including toxins associated with Alzheimer's disease.

Advisors to the Food and Drug Administration have recommended unanimously that the agency approve the Alzheimer’s drug donanemab.

President Biden and former President Trump have both experienced public memory lapses. But brain experts say such slips, on their own, are not a cause for concern.